David Rolfe Edwards Lifesciences Corp Transaction History
Wedgewood Partners Inc
- $466 Million
- Q1 2025
A detailed history of David Rolfe (Wedgewood Partners Inc) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wedgewood Partners Inc holds 191,818 shares of EW stock, worth $14.5 Million. This represents 2.98% of its overall portfolio holdings.
Number of Shares
191,818
Previous 339,436
43.49%
Holding current value
$14.5 Million
Previous $25.1 Million
44.68%
% of portfolio
2.98%
Previous 4.94%
Shares
31 transactions
Others Institutions Holding EW
# of Institutions
1,377Shares Held
486MCall Options Held
2.77MPut Options Held
2.05M-
Vanguard Group Inc Valley Forge, PA69.2MShares$5.25 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.86 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$2.21 Billion0.42% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.95 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.66 Billion0.12% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...